PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
Go back to PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada| (NASDAQ: PYPD) | Delayed: 5.33 -0.06 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.39 | 52 Week High | $ | |||
| Open | $5.39 | 52 Week Low | $ | |||
| Day High | $5.57 | P/E | N/A | |||
| Day Low | $5.24 | EPS | $ | |||
| Volume | 87,317 | |||||

